What are the benefits of cognitive enhancers for Alzheimer's Disease: use of Population Impact Measures

BACKGROUND: The study aims to quantify the population impact of prescribing cholinesterase inhibitors to slow the cognitive decline in Alzheimer's disease (AD), and to compare with the benefit of treating hypertension to prevent the onset of AD. METHODS: Literature review to ascertain the preva...

Descripción completa

Detalles Bibliográficos
Autores principales: Gammanpila, Udaya P, Burns, Alistair, Heller, Richard F, Purandare, Nitin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206022/
https://www.ncbi.nlm.nih.gov/pubmed/17986333
http://dx.doi.org/10.1186/1471-2318-7-25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206022/
https://www.ncbi.nlm.nih.gov/pubmed/17986333
http://dx.doi.org/10.1186/1471-2318-7-25

Ejemplares similares